Showing results (231-240 of 989) with videos related to
Sort By:
Pageof 99
European Urology|September 24, 2018
Epidemiology of Renal Cell CarcinomaUmberto Capitanio, Karim Bensalah, Axel Bex, et al.BJU International|August 20, 2008
Nephrectomy improves the survival of patients with locally advanced renal cell carcinomaLaurent Zini, Paul Perrotte, Claudio Jeldres, et al.Urology|November 29, 2008
Sex hormone-binding globulin: a novel marker for nodal metastases prediction in prostate cancer patients undergoing extended pelvic lymph node dissectionAndrea Salonia, Alberto Briganti, Andrea Gallina, et al.Cancer|October 14, 2009
Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspectiveGiovanni Lughezzani, Umberto Capitanio, Claudio Jeldres, et al.Contemporary Clinical Trials|July 30, 2014
A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT)Massimo Valerio, Louise Dickinson, Afia Ali, et al.The Journal of Urology|December 31, 2013
Morbidity associated with primary high intensity focused ultrasound and redo high intensity focused ultrasound for localized prostate cancerViktor Berge, Louise Dickinson, Neil McCartan, et al.Radiology|January 29, 2008
MR imaging of prostate after treatment with high-intensity focused ultrasoundAlexander P S Kirkham, Mark Emberton, Ivan M Hoh, et al.Scientific Reports|March 10, 2017
Engineering a vascularised 3D in vitro model of cancer progressionTarig Magdeldin, Víctor López-Dávila, Judith Pape, et al.Plos Medicine|December 21, 2019
Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling studyTom Callender, Mark Emberton, Steve Morris, et al.BJU International|October 17, 2013
Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT studyClaus G Roehrborn, Jack Barkin, Andrea Tubaro, et al.Pageof 99